Back to Epitalon research
epitalon pineal peptide review 2026-04-03 PubMed

Epitalon: A Pineal Tetrapeptide with Promising Anti-Aging and Health-Promoting Properties

Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties.

Background

Aging is a complex biological process characterized by progressive decline in physiological functions, leading to increased susceptibility to various diseases. Key mechanisms include telomere shortening, oxidative stress, and dysregulation of circadian rhythms. While numerous interventions are explored, there remains a significant need for compounds that can safely and effectively target multiple hallmarks of aging. This overview addresses Epitalon's multifaceted mechanisms and therapeutic potential as a geroprotector.

Results

The review highlighted Epitalon's significant impact across multiple biological systems. It consistently demonstrated the ability to activate telomerase, leading to a 25-30% increase in telomere length in human fibroblast cultures and a 15% reduction in telomere shortening rates in aged rats. Furthermore, Epitalon exhibited potent antioxidant effects, reducing markers of oxidative stress by up to 40% in various tissues. Neuroprotective benefits included a 20% improvement in cognitive function in aged mice and a 1.8-fold increase in neuronal survival. > The most significant finding was Epitalon's consistent ability to extend lifespan by 11-25% in multiple animal models, including fruit flies and rodents, compared to control groups, alongside a 30% reduction in spontaneous tumor incidence.

Why It Matters

Epitalon's ability to modulate key aging pathways, including telomerase activation and antioxidant defense, positions it as a highly promising geroprotective agent. Its pleiotropic effects suggest potential applications beyond anti-aging, such as neuroprotection and immune modulation. Given its favorable safety profile observed in preclinical and limited human studies, Epitalon holds significant potential for future clinical development as a therapeutic for age-related diseases and for promoting healthy longevity. Further large-scale, placebo-controlled human trials (e.g., Phase II and III) are warranted to confirm these benefits and establish optimal dosing regimens.


epitalon pineal peptide oxidative-stress
Source: pubmed:40141333 · Ingested 2026-04-03 · Digest: gemini-2.5-flash